TrianglePUBLICATIONS · 25517749
ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer Cell
- Publication date
- 2014 Nov 10
- First author
- Bresler SC
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Bresler SC
- type
- Author
- name
- Weiser DA
- type
- Author
- name
- Huwe PJ
- type
- Author
- name
- Park JH
- type
- Author
- name
- Krytska K
- type
- Author
- name
- Ryles H
- type
- Author
- name
- Laudenslager M
- type
- Author
- name
- Rappaport EF
- type
- Author
- name
- Wood AC
- type
- Author
- name
- McGrady PW
- type
- Author
- name
- Hogarty MD
- type
- Author
- name
- London WB
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Bresler SC
- type
- Author
- name
- Weiser DA
- type
- Author
- name
- Huwe PJ
- type
- Author
- name
- Park JH
- type
- Author
- name
- Krytska K
- type
- Author
- name
- Ryles H
- type
- Author
- name
- Laudenslager M
- type
- Author
- name
- Rappaport EF
- type
- Author
- name
- Wood AC
- type
- Author
- name
- McGrady PW
- type
- Author
- name
- Hogarty MD
- type
- Author
- name
- London WB
- type
- Author
- bibliography ids
- nci-bib-e055fd46a7f7ff1613787e53
- book metadata
- content sha256
- 7704d245c8454022072011be1c24edacf2af42aae69c31f1673dac4ac9702b37
- document type
- citation
- dois
- 10.1016/j.ccell.2014.09.019
- electronic publication date
- display
- 2014 Nov 10
- precision
- day
- year
- 2014
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:25517749
- immutable id
- pubmed:25517749@7704d245c8454022072011be1c24edacf2af42aae69c31f1673dac4ac9702b37
- journal
- abbreviation
- Cancer Cell
- issn electronic
- 1878-3686
- issn print
- 1535-6108
- issue
- 5
- name
- Cancer cell
- nlm unique id
- 101130617
- pages
- 682-94
- volume
- 26
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 25517749
- provenance
- batch id
- 863b068fe5a07222af6a
- provider
- NCBI PubMed ESummary
- record sha256
- bfe9b4fc03ec57fc255596fa4692789870e75286d551a2cf394ac1f24dafe9c8
- response sha256
- 80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
- retrieved at
- 2026-09-09T23:47:07.648963+00:00
- publication date
- display
- 2014 Nov 10
- precision
- day
- year
- 2014
- publication types
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.
Preserved source evidence · Independent clinical review pending · Not medical advice